Low density lipoprotein receptor mutations in a selected population of individuals with moderate hypercholesterolemia

被引:17
作者
Arca, M [1 ]
Jokinen, E [1 ]
机构
[1] Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75235 USA
关键词
LDL-receptor; hypercholesterolemia; familial hypercholesterolemia;
D O I
10.1016/S0021-9150(97)00210-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To evaluate mutations in the low density lipoprotein receptor (LDL-R) gene in moderate primary hypercholesterolemia, a combination of polymerase chain reaction (PCR), single-strand conformation polymorphism (SSCP) and direct sequencing, was used to screen the LDL-R gene in a selected population of 82 unrelated individuals with moderate elevation of plasma LDL-C [mean 4.55 +/- 0.55 mmol/l (176.4 +/- 21.6 mg/dl)]. Four subjects (5%) were found to be heterozygotes for missense mutations in the LDL-R gene. These mutations were located in four different exons (exons 6, 7 15 and 17) and all alters highly conserved residues of LDL-R protein. None of these mutations were detected in 79 normocholesterolemic individuals. The mutation in exon 15 (T705I) was previously reported in a compound heterozygote for familial hypercholesterolemia (FH). In the proband carrying the mutation in exon 17 (R793Q), an in vivo LDL turnover study was performed and it demonstrated a reduction of LDL catabolism. These findings demonstrate that mutations in the LDL-R may occur in primary moderate hypercholesterolemia. They also extend the concept that some FH patients may present with a mild phenotype. (C) 1998 Elsevier Science Ireland Ltd.
引用
收藏
页码:187 / 194
页数:8
相关论文
共 27 条
[1]   HYPERCHOLESTEROLEMIA IN POSTMENOPAUSAL WOMEN - METABOLIC DEFECTS AND RESPONSE TO LOW-DOSE LOVASTATIN [J].
ARCA, M ;
VEGA, GL ;
GRUNDY, SM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (06) :453-459
[2]  
CLEEMAN JI, 1988, ARCH INTERN MED, V148, P36, DOI 10.1001/archinte.148.1.36
[3]  
DAVIS CG, 1987, J BIOL CHEM, V262, P4075
[4]  
*DEP HLTH ED WELF, 1984, DEP HLTH ED WELF P F, V5628
[5]  
ESSER V, 1988, J BIOL CHEM, V263, P13283
[6]  
Goldstein JL, 1989, METABOLIC BASIS INHE, P1215
[7]   MULTIFACTORIAL ETIOLOGY OF HYPERCHOLESTEROLEMIA - IMPLICATIONS FOR PREVENTION OF CORONARY HEART-DISEASE [J].
GRUNDY, SM .
ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (06) :1619-1635
[8]   ABSENCE OF FAMILIAL DEFECTIVE APOLIPOPROTEIN-B-100 IN FINNISH PATIENTS WITH ELEVATED SERUM-CHOLESTEROL [J].
HAMALAINEN, T ;
PALOTIE, A ;
AALTOSETALA, K ;
KONTULA, K ;
TIKKANEN, MJ .
ATHEROSCLEROSIS, 1990, 82 (03) :177-183
[9]  
Hobbs Helen H., 1992, Human Mutation, V1, P445, DOI 10.1002/humu.1380010602
[10]  
HOBBS HH, 1986, J BIOL CHEM, V261, P3114